Algernon Pharmaceuticals Inc.
|
|||
| Mailing Address: | Suite 915 - 700 West Pender Street Vancouver, BC V6C 1G8 |
Head Office Address: | Suite 915 - 700 West Pender Street Vancouver, BC V6C 1G8 |
| Contact Name: | Michael Sadhra | Principal Regulator: | British Columbia |
| Business e-mail address: | n/a | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 604 646-1553 | Reporting Jurisdictions: | British Columbia, Alberta, Ontario |
| Fax Number: | Stock Exchange: | Canada - CSE | |
| Date of Formation: | Apr 10 2015 | Stock Symbol: | AGN |
| Jurisdiction Where Formed: | British Columbia | Auditor: | Smythe LLP |
| Industry Classification: | junior industrial | General Partner: | |
| CUSIP Number: | 01559R | Transfer Agent: | AST Trust Company (Canada) |
| Financial Year-End: | Aug 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
